Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

M4OC-Prevent: Metformin for Oral Cancer Prevention

NCT02581137 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT02581137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02581137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
M4OC-Prevent: Metformin for Oral Cancer Prevention
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Active, not recruiting
Start date
June 10, 2016
Completion date
December 19, 2026
Enrollment
26 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

erythroplakia, hyperplasia, oral cavity carcinoma, oral leukoplakia